We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
+4.72%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$548M
AUM Growth
-$89.4M
(-14%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-19.59%
Top 10 Holdings %
Top 10 Hldgs %
24.74%
Holding
348
New
22
Increased
127
Reduced
117
Closed
29
Top Buys
| 1 |
DexCom
DXCM
|
+$7.61M |
| 2 |
Edwards Lifesciences
EW
|
+$5.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$4.47M |
| 4 |
Dollar General
DG
|
+$4.1M |
| 5 |
LPL Financial
LPLA
|
+$3.22M |
Top Sells
| 1 |
K
Kellanova
K
|
+$13.1M |
| 2 |
MarketAxess Holdings
MKTX
|
+$8.31M |
| 3 |
Newmont
NEM
|
+$7.69M |
| 4 |
Eli Lilly
LLY
|
+$6.64M |
| 5 |
United Therapeutics
UTHR
|
+$6.19M |
Sector Composition
| 1 | Healthcare | 32.67% |
| 2 | Consumer Staples | 19.07% |
| 3 | Technology | 15.04% |
| 4 | Financials | 9.84% |
| 5 | Communication Services | 8.1% |
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q3 2024 Portfolio in Review
As of Q3 2024, TOBAM held 348 positions worth $548M, down 14% from $638M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
TOBAM withdrew a net $107M in Q3 2024, closing 29 positions and reducing 117 holdings. Its most notable exit was Kellanova, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 31% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, TOBAM opened a new position in Incyte worth $878K.
- TOBAM's largest Q3 2024 buy was Incyte: 13,276 shares worth $878K.
- TOBAM added most to DexCom in Q3 2024, an estimated $7.61M increase.
- TOBAM's biggest Q3 2024 reduction was Newmont, cutting an estimated $7.69M.
- TOBAM fully exited Kellanova in Q3 2024, selling an estimated $13.1M.
- TOBAM's ten largest holdings make up 25% of its $548M portfolio in Q3 2024.
- TOBAM opened 22 new positions and closed 29 in Q3 2024.
- TOBAM's portfolio value fell 14% quarter-over-quarter to $548M.
Based on TOBAM's 13F filing for Q3 2024, filed 9 Oct 2024.